UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043655
Receipt number R000049853
Scientific Title Modified Ablation Index: A Novel Determinant of Successful First-Pass Left Atrial Posterior Wall Isolation
Date of disclosure of the study information 2021/03/20
Last modified on 2022/03/24 22:19:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study to clarify factors contributing to improved success rate of left atrial posterior wall isolation in patients with atrial fibrillation

Acronym

Study of Success Factors for Left Atrial posterior wall Isolation

Scientific Title

Modified Ablation Index: A Novel Determinant of Successful First-Pass Left Atrial Posterior Wall Isolation

Scientific Title:Acronym

Modified AI as a Determinant of First-Pass LAPWI

Region

Japan


Condition

Condition

Atrial fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to examine whether the parameters such as wall thickness, local potential in left atrial posterior wall, and modified AI can be an index for predicting the success of left atrial posterior wall isolation in the patients with atrial fibrillation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Wall thickness and potential characteristics at left atrial posterior wall between the groups with successful LAPWI and failed LAPWI.

Key secondary outcomes

Age, sex, BW, BMI, CHADs2 score, comorbidities, history of atrial fibrillation, renal function, cardiac function, medication content ,and recurrence of atrial fibrillation after ablation between groups with successful LAPWI and failed LAPWI.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Among patients who underwent catheter ablation for atrial fibrillation

(1) Patients who underwent ablation using the CARTO system of the 3D mapping system
(2) Patients whose potential in the left chamber can be measured without excess or deficiency

Key exclusion criteria

Patients who are judged by the principal investigator to be inappropriate as research subjects

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yasuo
Middle name
Last name Okumura

Organization

Nihon University School of Medicine

Division name

Division of Cardiology

Zip code

173-8610

Address

30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan

TEL

03-3972-8111

Email

yasuwo128@yahoo.co.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Hayashida

Organization

Nihon University School of Medicine

Division name

Division of Cardiology

Zip code

173-8610

Address

30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan

TEL

03-3972-8111

Homepage URL


Email

satoshi.hayashida1@gmail.com


Sponsor or person

Institute

Nihon University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nihon University School of Medicine

Address

30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan

Tel

03-3972-8111

Email

satoshi.hayashida1@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

55

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 08 Month 01 Day

Date of IRB

2020 Year 05 Month 13 Day

Anticipated trial start date

2019 Year 08 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2022 Year 03 Month 31 Day


Other

Other related information

Exploratory observational study
Recruitment method: Patients who underwent catheter ablation for atrial fibrillation at our facility in August 2019-February 2020.


Management information

Registered date

2021 Year 03 Month 18 Day

Last modified on

2022 Year 03 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049853


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name